Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 3

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
Mutations in several genes and gene copy number variants are associated with neurodevelopmental disorders including autism spectrum disorders (ASD). Several gene products putatively implicated in ASD are frequently part of signaling networks involved in synapse formation and/or function leading to changes in the balance between excitation and inhibition (E/I balance). The network of parvalbumin (PV)-expressing interneurons has gained particular attention in ASD, yet not much is currently known on PV’s possible role with respect to ASD. PV-knockout mice were subjected to a battery of behavioral experiments testing for ASDlike, schizophrenia-like and anxiety-related behavior. PV-/- mice display the three core symptoms present in ASD patients: impaired social interactions, reduced communication and repetitive and stereotyped behavior. In addition, they also show ASDassociated developmental neuroanatomical changes in the neocortex and the cerebellum. Using electrophysiology, we observed that the E/I balance is altered by modification of both, inhibitory and excitatory synaptic transmission. Based on the reported changes in PV expression pattern in numerous mouse ASD models, we suggest a convergent pathway in ASD, where mutations in ASDlinked genes may lead to (homeostatic) adaptations causing a down-regulation of PV that ultimately results in the ASD phenotype.
Parvalbumin (PV) is a calcium-binding protein expressed in a subpopulation of mostly GABAergic neurons in several brain regions, e.g. cortex and striatum. A reduction in the number of PVimmunopositive (PV+ ) neurons or a decrease in the intensity of PV immunoreactivity was reported in several mouse models of autism spectrum disorders (ASD) including mice with mutations in Shank genes. We have previously shown that the absence or reduction of PV in PV-/- and PV+/- mice, respectively, leads to a robust ASDlike phenotype, evidenced by all core symptoms including impairment in social interaction and communication, as well as repetitive and stereotyped patterns of behavior. We investigated whether the “reduction in PV+ neurons” in knockout mice for Shank1, Shank3 and PV+/- mice was the result of a decrease in PV expression levels and/or partial loss of the PVergic neuron subpopulation. We applied stereological methods to estimate the number of PVergic neurons in ASD-associated brain regions of PV-/-, PV+/-, Shank1-/- and Shank3B-/- mice. Vicia Villosa Agglutinin (VVA) was used to identify the specific extracellular matrix components enwrapping PVergic neurons. Quantitative levels of PV protein and Pvalb mRNA were analyzed by Western blot analyses and qRT-PCR, respectively. The analyses of cell numbers in different brain regions revealed that the observed “reduction of PV+ neurons” resulted from a reduction in Pvalb mRNA and PV protein. The unaltered numbers of VVA+ neurons are not compatible with a PV cell decrease/loss in these ASD models. We hypothesize that the down-regulation of PV in PVergic networks leads to an impairment of the excitation/inhibition balance and might signify a convergent downstream endpoint for some forms of ASD. Restoring of normal PV protein levels and/ or of PV+ neuron function might serve as a novel therapeutic strategy to avoid and/or possibly reverse the ASD phenotype.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.